We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The U.S. Court of Appeals for the Federal Circuit recently overturned the verdict reached by a jury in the Federal Court for the Northern District of Indiana concerning biomaterials derived from bladder tissue for use as medical products.
Hyderabad-based Suven Life Sciences has signed an agreement with US-based Eli Lilly and Company to collaborate on pre-clinical research of molecules in the therapeutic area of central nervous system (CNS) disorders.
A Florida man linked to a drug counterfeiting case involving a Leawood pharmaceutical executive pleaded guilty in federal court Monday to his role in the multimillion-dollar conspiracy to sell stolen Lipitor.
Schering-Plough Corp. said Tuesday it has agreed to pay $435 million and will plead guilty to conspiracy to settle a federal investigation into its drug sales and marketing practices and its clinical trial programs.
A drug to help women carry their babies to term that is awaiting federal approval doesn't appear to delay the earliest preterm births most often linked to death and serious health problems, according to federal documents released Monday.
Attorneys representing Par Pharmaceutical's investors have filed a lawsuit after the company announced it would restate its previously reported financial results.
GlaxoSmithKline (GSK) has revised the prescribing information for its attention-deficit/hyperactivity disorder (ADHD) drug Dexedrine to indicate that the drug can cause sudden death in patients with heart abnormalities.
The FDA's rush to meet drug review timelines under the Prescription Drug User Fee Act (PDUFA) may lead to more postmarketing safety problems, a Harvard University professor said.